The funding will be allocated to significantly augment manufacturing capacity to meet current and future customer demand, expansion of the existing team with key commercial and operations specialists and additions to the IP portfolio family.
Membrion manufactures ceramic desalination membranes that can recover up to 98% of water in harsh environments.
The Seattle-based company was founded in 2016 to address the challenges in industrial wastewater where the only method of dealing with these hard-to-treat discharges was trucking. Membrion CeramIX desalination membranes offer a cost-effective on-site option for the removal of problematic metals, minerals, and salts, and help industry to achieve its zero discharge aspirations.
“It’s mind boggling to me that we still pump wastewater onto trucks and drive it somewhere else to be treated. We're seeing pilot projects convert to full commercial installations, which makes the more sustainable option, treating water on-site, an economically attractive reality. It’s exciting,” said Membrion CEO and co-founder Greg Newbloom. “This Series B investment helps to solidify our vision of phasing out inefficient legacy water treatment processes.”
“Membrion brings to the market a membrane technology like no other we have seen, and we have seen a lot,” said Nic Pannekeet, managing partner at PureTerra. “Greg and his talented team have put a twist on the traditional EDR build by the inclusion of ceramic which opens a much wider field of application. We couldn’t be more excited to add Membrion to our portfolio and we look forward to helping this unique technology reach its potential.”
“At GiantLeap, we partner with companies with platform technologies within critical industries where we can meaningfully advance ESG,” said Himanshu Sekhar, GiantLeap’s co-founder and managing partner. “Membrion brings an elegant solution for critical water infrastructure with diverse applicability across a number of sectors. Greg is an exceptional leader and we are looking forward to actively engaging with him on our value creation playbooks to catalyze the next stage of Membrion's growth.”
Pannekeet and Sekhar will now join Membrion’s board of directors.